DEF: USANA Health Sciences Sets Date for 2025 Annual Shareholder Meeting, Seeks Approval for Equity Incentive Plan
Proxy Statement
USANA Health Sciences announces its 2025 Annual Meeting of Shareholders to be held virtually on May 19, 2025, with key proposals including director elections, approval of a new equity incentive plan, and ratification of the independent auditor.
Summary
- USANA Health Sciences will hold its Annual Meeting of Shareholders virtually on May 19, 2025.
- Shareholders of record as of March 10, 2025, are eligible to vote.
- The meeting will address the election of eight directors, approval of the 2025 Equity Incentive Plan, ratification of KPMG as the independent auditor, and an advisory vote on executive compensation.
- The Board recommends voting 'FOR' all proposals.
- The company is providing proxy materials online, reducing printing and distribution costs.
- The 2025 Equity Incentive Plan seeks shareholder approval for 2,500,000 shares plus shares remaining from the 2015 plan, to continue equity awards to directors, officers, employees and consultants.
- The Board has adopted a clawback policy for excess incentive compensation earned by Section 16 Officers in the event of an accounting restatement.
- Non-employee directors receive an annual cash retainer of $91,400, with additional amounts for committee chairs.
- The company prohibits executive officers and board members from pledging USANA securities and engaging in hedging transactions.
- The company's Code of Ethics applies to all directors, officers, and employees.
Sentiment
Score: 7
Explanation: The document is generally positive, outlining standard corporate governance procedures and seeking approval for initiatives. There are no significant negative indicators, but it is a formal document, so the sentiment is moderately positive.
Positives
- The company is committed to good corporate governance, as evidenced by its various policies and committees.
- The company is actively involved in risk oversight and management.
- The company is providing proxy materials online to conserve resources and reduce costs.
- The company has a clawback policy in place.
- The company has stock ownership requirements for directors and executive officers to align their interests with shareholders.
- The company prohibits executive officers and board members from pledging USANA securities and engaging in hedging transactions.
Negatives
- The document does not explicitly state any negative aspects of the company's performance or governance.
- The document does not explicitly state any negative aspects of the company's compensation.
Risks
- The document does not explicitly state any risks to the company.
- The document does not explicitly state any risks to the company's compensation.
Future Outlook
The company is seeking shareholder approval for the 2025 Equity Incentive Plan to continue providing equity awards to directors, executive officers, employees and consultants.
Management Comments
- Kevin Guest, Executive Chairman of the Board, invites shareholders to participate in the Annual Meeting and emphasizes the importance of their vote.
- The Board believes that strong, independent Board leadership is an important aspect of corporate governance and beneficial to USANA and our shareholders.
Industry Context
The document provides information relevant to the direct selling, nutritional, and personal product industries, as USANA operates within these sectors. The company benchmarks itself against other publicly traded companies in these industries for compensation and performance purposes.
Comparison to Industry Standards
- The Compensation Committee uses a Compensation Peer Group of 15 publicly traded direct selling, nutritional or personal product companies to benchmark the Company's position in its use of cash and equity compensation for executives.
- The Performance Peer Group consists only of publicly traded direct selling companies, including some who are in the broader Compensation Peer Group.
- The Performance Peer Group is used to assess the Company's overall operating performance relative to the performance of these direct peers.
- The company benchmarks itself against other publicly traded companies in these industries for compensation and performance purposes.
Stakeholder Impact
- Shareholders are invited to participate in the Annual Meeting and vote on key proposals.
- The company's compensation policies are designed to align the interests of executives with those of shareholders.
- The company's sustainability efforts and ethical practices are intended to benefit all stakeholders.
Next Steps
- Shareholders are encouraged to vote on the proposals outlined in the Proxy Statement.
- The company will hold its Annual Meeting of Shareholders on May 19, 2025.
- The Board will consider the results of the advisory vote on executive compensation when structuring future compensation arrangements.
- The Board will act on the Governance, Risk & Nominating Committee's recommendation regarding any director resignations tendered under the plurality plus voting standard.
Key Dates
| Date | Description |
|---|---|
| 2019-12-29 | Date listed in relation to Mr. Guest's equity awards. |
| 2021-01-02 | Date listed in relation to Mr. Guest's equity awards. |
| 2021-01-03 | Date listed in relation to Mr. Guest's equity awards. |
| 2022-01-02 | Date listed in relation to Mr. Guest's equity awards. |
| 2023-01-01 | Date listed in relation to Mr. Brown's equity awards. |
| 2023-12-31 | Date listed in relation to Mr. Brown's equity awards. |
| 2024-12-28 | End of Fiscal Year 2024. |
| 2025-03-10 | Record date for the Annual Meeting. |
| 2025-04-04 | Date of mailing the Notice of Internet Availability of Proxy Materials. |
| 2025-05-19 | Date of the Annual Meeting of Shareholders. |
| 2026-01-03 | Date listed in relation to KPMG as our independent registered public accounting firm. |
| 2026-05-04 | Currently scheduled date for the 2026 Annual Meeting. |
Keywords
USANA, shareholders, directors, equity incentive plan, KPMG, executive compensation, proxy statement, annual meeting, governance, compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.